Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura

Carolyn M. Bennett, Zora R. Rogers, Daniel D. Kinnamon, James B. Bussel, Donald H. Mahoney, Thomas C. Abshire, Hadi Sawaf, Theodore B. Moore, Mignon L. Loh, Bertil E. Glader, Maggie C. McCarthy, Brigitta U. Mueller, Thomas A. Olson, Adonis N. Lorenzana, William C. Mentzer, George R. Buchanan, Henry A. Feldman, Ellis J. Neufeld

Research output: Contribution to journalArticlepeer-review

177 Scopus citations

Fingerprint Dive into the research topics of 'Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds